ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselNoema Pharma AG
Noema Pharma AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Noema Pharma AG is a biotechnology company developing oral small-molecule drug candidates for neurological and related disorders. Its clinical programs include treatments for trigeminal neuralgia and menopause-related vasomotor symptoms such as hot flashes and night sweats.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Noema Pharma AG

✓ Offered5
Development of oral small-molecule therapeutics
Late-stage development of oral small-molecule therapeutics with well-characterised mechanisms of action for neurological and related diseases.
Clinical programs for trigeminal neuralgia
Clinical development programme for the treatment of pain in trigeminal neuralgia with Basimglurant (NOE-101), Phase 2/3.
Clinical programs for vasomotor symptoms of menopause
Clinical development programme for non-hormonal treatment of vasomotor symptoms of menopause, including hot flushes and night sweats, with Cendifensine (NOE-115).
Educational materials on neurological diseases and menopause symptoms
Information and resource offerings on trigeminal neuralgia and menopause-related vasomotor symptoms for patients, families, caregivers and professionals.
Partnerships and investor relations
Strategic collaborations and investments to develop treatments for rare and often overlooked diseases of the nervous system.
Trust & reputation

ranQ Trust Score of Noema Pharma AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

Noema Pharma AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Noema Pharma AG scores 79.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Noema Pharma AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Noema Pharma AG scores 48.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.48.64%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Noema Pharma AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Noema Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Noema Pharma AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Noema Pharma AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Noema Pharma AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Barfüsserplatz 3
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-420.678.302
Founded
2020 · 6 years
Last commercial register change
August 31, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AP
    Acadia Pharmaceuticals GmbH
    Basel
    IS
    Immunovant Sciences GmbH
    Basel
    ST
    Synendos Therapeutics AG
    Basel
    LP
    Luye Pharma Switzerland AG
    Basel
    SL
    S. L. A. Pharma AG
    Basel
    ST
    Skyhawk Therapeutics Europe GmbH
    Basel
    FT
    FoRx Therapeutics AG
    Basel
    RP
    Rhizen Pharmaceuticals AG
    Basel